NADINE H YASSA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology ROSEVILLE, CA NPI 1689656647
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology CA LivaNova USA, Inc. All categories
General Payments — all program years on this page
$16,337.67
- Category: General Payments
- Program years: PY2018–2024
- Record count: 599
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,346.96 across 100 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,647.53 | 96 |
| Travel and Lodging | $696.93 | 2 |
| Education | $2.50 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| LivaNova USA, Inc. | $1,265.02 | 9 |
| UCB, Inc. | $710.80 | 39 |
| Neurocrine BioSciences, Inc. | $337.95 | 9 |
| SK Life Science, Inc. | $246.87 | 8 |
| ABBVIE INC. | $174.30 | 12 |
| Teva Pharmaceuticals USA, Inc. | $96.03 | 5 |
| Janssen Pharmaceuticals, Inc | $95.85 | 1 |
| JAZZ PHARMACEUTICALS INC. | $63.78 | 2 |
| Kyowa Kirin, Inc. | $56.11 | 2 |
| Lilly USA, LLC | $55.21 | 2 |
| ACADIA Pharmaceuticals Inc | $54.06 | 2 |
| Lundbeck LLC | $49.10 | 2 |
| Sumitomo Pharma America, Inc. | $41.55 | 2 |
| Amneal Pharmaceuticals LLC | $23.83 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.27 | 1 |
| Aucta Pharmaceuticals, Inc. | $20.63 | 1 |
| Averitas Pharma Inc. | $17.90 | 1 |
| Celgene Corporation | $16.70 | 1 |
By program year
Records — PY2024 (100)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.